Matrix Capital Management Company, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Adaptimmune Therapeutics plc Ordinary Shares, par value 0.001 GBP per share (ADAP)

Filing Manager: Matrix Capital Management Company, LP
Reporting Manager: Matrix Capital Management Company LP
Security: Adaptimmune Therapeutics plc Ordinary Shares, par value 0.001 GBP per share
Symbol: ADAP
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Filing time: 08 Jan 2025, 10:30:10 UTC
Date of event: 31 Dec 2024
Previous filing: 05 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Matrix Capital Management Company LP	0%	0	0	0	/s/ David E. Goel	David E. Goel, Managing General Partner
David E. Goel	0%	0	0	0	/s/ David E. Goel	David E. Goel, individually